Table 4.
Description of demographic, dietary intake, and metabolic differences between age, race, and gender matched schizophrenia and bipolar disorder patients with and without metabolic syndrome.
| Variable | With Metabolic Syndrome (n = 62) |
Without Metabolic Syndrome (n = 94) |
p- value |
|---|---|---|---|
| Demographics | |||
| Age ± s.d. (years) | 48.7 ± 9.7 | 43.5 ± 11.1 | 0.004 |
| Percent Caucasian/African American | 83%/12% | 79%/16% | 0.92 |
| Percent Male | 60% | 60% | 0.90 |
| % Schizophrenia/ % Bipolar | 47%/53% | 52%/47% | 0.51 |
| AAP use (%) | 68% | 57% | 0.17 |
| Mean Cumulative Chlorpromazine Equivalents (mg) |
438.7 ± 439.0 | 401.9 ± 379.1 | 0.58 |
| Current receiving a mood stabilizer (%) | 55% | 55% | 0.95 |
| Currently receiving an antidepressant (%) |
69% | 49% | 0.01 |
| Dietary and Lifestyle Parameters | |||
| Percent Current Smoker | 53% | 41% | 0.15 |
| Mean Total Calories consumed/day ± s.d. (Kcals) |
1973.9 ± 657.6 | 1973.2 ± 737.5 | 0.96 |
| Total Activity Score (TAM2) ± s.d. MET/min |
2902 ± 2797 | 3738 ± 3856 | 0.35 |
| Mean Carbohydrates consumed ± s.d. (kcals/day) |
245.2 ± 92.9 | 251.0 ± 101.1 | 0.72 |
| Mean Saturated Fatty Acids (SFAs) consumed ± s.d. (grams/day) |
27.5 ± 13.5 | 26.5 ± 12.6 | 0.63 |
| Mean Dietary Fiber consumed ± s.d. (grams/day) |
17.8 ± 8.9 | 18.2 ± 9.5 | 0.83 |
| Mean Total Fat consumed ± s.d. (grams/day) |
79.9 ± 34.8 | 77.7 ± 34.5 | 0.69 |
| Mean Poly unsaturated Fats (PUFAs) consumed ± s.d. (grams/day) |
16.6 ± 9.1 | 16.9 ± 8.7 | 0.85 |
| Mean Vitamin D consumed ± s.d. (micrograms/day) |
7.7 ± 7.7 | 7.4 ± 12.7 | 0.87 |
| Glycemic Index (Glucose Reference) | 59.7 ± 4.8 | 59.8 ± 7.1 | 0.93 |
| Mean Omega-3 Fatty Acids consumed ± s.d (grams/day) |
1.6 ± 0.9 | 1.8 ± 1.0 | 0.38 |
| Mean Omega-6 Fatty Acids consumed ± s.d (grams/day) |
16.3 ± 8.9 | 16.7 ± 8.7 | 0.80 |
| Mean Omega-6/Omega-3 | 11.0 ± 4.4 | 10.4 ± 4.6 | 0.64 |